Abstract
The relative efficacies of cytotoxic chemotherapy regimens in the treatment of advanced breast cancer are generally assessed by comparing response rates in randomised trials. Treatment attempts to prolong survival but trials rarely demonstrate a statistically significant survival advantage: it has been argued that chemotherapy does not prolong survival. The correlation between response rates and survival has been examined by reviewing 79 comparisons between arms with unequal response rates in 50 published trials of chemotherapy in advanced breast cancer. In 73% of comparisons the group with the higher response rate also demonstrated the longer median survival (P less than 0.001). Weighted linear regression showed a statistically significant relationship between relative response rates and survival (P less than 0.001). The number of patients in a comparison did not influence this relationship.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRINKLEY D., HAYBITTLE J. L. Results of treatment of carcinoma of the breast. Lancet. 1959 Jan 10;1(7063):86–90. doi: 10.1016/s0140-6736(59)91152-3. [DOI] [PubMed] [Google Scholar]
- Brambilla C., De Lena M., Rossi A., Valagussa P., Bonadonna G. Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J. 1976 Apr 3;1(6013):801–804. doi: 10.1136/bmj.1.6013.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chalmers T. C., Levin H., Sacks H. S., Reitman D., Berrier J., Nagalingam R. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. Stat Med. 1987 Apr-May;6(3):315–328. doi: 10.1002/sim.4780060320. [DOI] [PubMed] [Google Scholar]
- Devitt J. E., Advent D. A. Effect of current palliative treatment on the survival of patients with breast cancer. Can J Surg. 1977 Jan;20(1):46–50. [PubMed] [Google Scholar]
- Langlands A. O., Pocock S. J., Kerr G. R., Gore S. M. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J. 1979 Nov 17;2(6200):1247–1251. doi: 10.1136/bmj.2.6200.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel J. K., Nemoto T., Vezeridis M., Petrelli N., Suh O., Dao T. L. Does more intense palliative treatment improve overall survival in metastatic breast cancer patients? Cancer. 1986 Feb 1;57(3):567–570. doi: 10.1002/1097-0142(19860201)57:3<567::aid-cncr2820570328>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Paterson A. H., Szafran O., Cornish F., Lees A. W., Hanson J. Effect of chemotherapy on survival in metastatic breast cancer. Breast Cancer Res Treat. 1981;1(4):357–363. doi: 10.1007/BF01806751. [DOI] [PubMed] [Google Scholar]
- Powles T. J., Coombes R. C., Smith I. E., Jones J. M., Ford H. T., Gazet J. C. Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet. 1980 Mar 15;1(8168 Pt 1):580–582. doi: 10.1016/s0140-6736(80)91066-1. [DOI] [PubMed] [Google Scholar]
- Priestman T., Baum M., Jones V., Forbes J. Treatment and survival on advanced breast cancer. Br Med J. 1978 Dec 16;2(6153):1673–1674. doi: 10.1136/bmj.2.6153.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross M. B., Buzdar A. U., Smith T. L., Eckles N., Hortobagyi G. N., Blumenschein G. R., Freireich E. J., Gehan E. A. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer. 1985 Jan 15;55(2):341–346. doi: 10.1002/1097-0142(19850115)55:2<341::aid-cncr2820550206>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
- Rubens R. D., Armitage P., Winter P. J., Tong D., Hayward J. L. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer. 1977 Aug;13(8):805–811. doi: 10.1016/0014-2964(77)90134-7. [DOI] [PubMed] [Google Scholar]